0000000000161137

AUTHOR

Lutz Edler

showing 4 related works from this author

The Extinction of Generations in Generation-Dependent Bellman-Harris Branching Processes with Exponential Lifespan

1978

If V is the time when in a Bellman-Harris branching model the k-th generation disappears out of the population, and if all individuals have exponentially distributed lifespans, the asymptotic behavior of the tail of the distribution of the extinction time V , P(V > t), is obtained, even if the distributions of the lifespans and the offspring sizes vary generation-dependent. Furthermore the times of extinction of several successive generations can be specified for the generation- independent case of the Markov branching model in continuous time. If the initial number of individuals and the absolute time grow up appropriately linked, a Poisson limit theorem for generation sizes will be given.

Branching (linguistics)education.field_of_studyDistribution (mathematics)ExtinctionExponential distributionMarkov chainPopulationQuantitative Biology::Populations and EvolutionStatistical physicseducationExponential functionMathematicsPoisson limit theorem
researchProduct

Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners

1998

One hundred ninety-two workers in a German pesticide factory who were exposed to polychlorinated dibenzodioxins and -furans (PCDD/PCDF) were investigated for former and present diseases and laboratory changes of the immune system. Moreover, in a subgroup of 29 highly exposed and 28 control persons, proliferation studies were performed. In addition to assays such as blood count, immunoglobulins, serum electrophoresis, monoclonal bands, surface markers, autoantibodies, and lymphocyte proliferation, two new methods, the rise of tetanus antibody concentration after vaccination and the in vitro resistance of lymphocytes to chromate, were used to diagnose the morphologic and functional state of t…

AdultMalePolychlorinated DibenzodioxinsHealth Toxicology and MutagenesisPolychlorinated dibenzodioxinsLymphocyte proliferationLymphocyte ActivationCohort Studieschemistry.chemical_compoundImmune systemImmunityOccupational ExposuremedicineChromatesTetanus ToxoidHumansPesticidesPhytohemagglutininsFuransAgedImmunity CellularbiologyTetanusPublic Health Environmental and Occupational HealthAutoantibodyMiddle Agedmedicine.diseaseVaccinationchemistryChemical IndustryImmunologyAntibody Formationbiology.proteinFemaleAntibodyResearch Article
researchProduct

Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy

2005

The glucocorticoid dexamethasone is frequently used as co-treatment in cytotoxic cancer therapy, e.g. to prevent nausea, to protect normal tissue or for other reasons. While the potent pro-apoptotic properties and the supportive effects of glucocorticoids to tumour therapy in lymphoid cells are well studied, the impact to cytotoxic treatment of colorectal and hepatocellular carcinoma is unknown. We tested apoptosis-induction, viability, tumour growth and protein expression using 8 established cell lines, 18 surgical specimen and a xenograft on nude mice. In the presence of dexamethasone we found strong inhibition of apoptosis in response to 5-FU, cisplatin, gemcitabine or gamma-irradiation,…

OncologyCancer Researchmedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentMice NudeAntineoplastic AgentsApoptosisDexamethasoneMiceGlucocorticoid receptorCell Line TumorInternal medicineCarcinomamedicineAnimalsHumansNeoplasm MetastasisGlucocorticoidsDexamethasoneCisplatinChemotherapybusiness.industryAnti-Inflammatory Agents Non-SteroidalLiver NeoplasmsCancermedicine.diseaseGemcitabineOncologyHepatocellular carcinomaFemaleColorectal NeoplasmsbusinessNeoplasm Transplantationmedicine.drugCancer Letters
researchProduct

Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.

2003

Abstract Persistent infection with human papillomavirus (HPV), particularly HPV16, represents the prime risk factor in cervical carcinogenesis. HPV variants ( e.g. , within the E6 gene) together with immunogenetic factors of the host may be responsible either for effective viral clearance, or alternatively, for viral persistence. Peripheral blood from 27 HPV16 positive Swedish women with cervical carcinoma, who had previously been tested for HPV16 E6 variants, was used for human leukocyte antigen (HLA) class I typing. Women with HLA-B*44, HLA-B*51, or HLA-B*57 who were infected with the HPV16 E6 variant L83V had an approximately four- to fivefold increased risk for cancer compared with cont…

ImmunologyUterine Cervical NeoplasmsHuman leukocyte antigenBiologyEpitopeHLA AntigensRisk FactorsmedicineImmunology and AllergyHumansGenetic Predisposition to DiseaseTypingAlleleGenePapillomaviridaeCervical cancerSwedenPapillomavirus InfectionsHPV infectionGeneral MedicineOdds ratioOncogene Proteins Viralmedicine.diseaseVirologyRepressor ProteinsTumor Virus InfectionsImmunologyFemaleAlgorithmsHuman immunology
researchProduct